Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01566539 · ClinicalTrials.gov registry record · NA
Biological Basis of Individual Variation in Social Cooperation
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 707
- Enrollment target
NCT01566539 is a NA study that has completed, run by Emory University. The registered enrollment target is 707 participants.
The verdict
NCT01566539, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 707 participants
- Enrollment target
Study Summary
The project has three overall objectives. The first is to determine whether and how administration of intranasal oxytocin (OT) and intranasal vasopressin (AVP) influence cooperative decision-making and neural responses to cooperative and un-cooperative social interactions. The second is to determine whether and how intranasal vasopressin influences subjective evaluations of and neural responses to same and opposite-sex face stimuli and to determine if any of these effects persist beyond the period of AVP exposure. The third objective is to determine if intranasal OT influences empathy-related behavior and associated brain activity.
Interventions
- DRUG Intranasal Oxytocin (OT) 24 IU
- DRUG Intranasal Vasopressin (AVP)
- DRUG Intranasal Placebo
- DRUG Intranasal Vasopressin (AVP) 40 IU
- DRUG Lorazepam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 707 participants |
| Start Date | 2008-04 |
| Est. Completion | 2016-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01566539
The ClinicalTrials.gov registry entry for NCT01566539 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 707 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Intranasal Oxytocin (OT) 24 IU is the first listed.
NCT01566539 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01566539 about?
NCT01566539 is a clinical study titled "Biological Basis of Individual Variation in Social Cooperation". The project has three overall objectives. The first is to determine whether and how administration of intranasal oxytocin (OT) and intranasal vasopressin (AVP) influence cooperative decision-making and neural responses to cooperative and un-cooperative social interactions. The second is to determine...
What is the current status of trial NCT01566539?
This trial is currently completed. It is a NA study. The enrollment target is 707 participants. The study started on 2008-04. Estimated completion is 2016-11.
What interventions are being tested in trial NCT01566539?
The interventions under investigation include: Intranasal Oxytocin (OT) 24 IU (DRUG), Intranasal Vasopressin (AVP) (DRUG), Intranasal Placebo (DRUG), Intranasal Vasopressin (AVP) 40 IU (DRUG), Lorazepam (DRUG).
Who is sponsoring clinical trial NCT01566539?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.